MITF and melanoma: In this model, expressions of AXL and WNT5A define a distinct MITF‐negative population of melanoma cells, where MITF expression is not linked to BRN2 and the MAPK pathway and cells are MAPK pathway inhibitor unresponsive (Figure 2).